At a glance
What is inflammatory signalling?
It is communication between cells that coordinates defence against infection or injury and helps organise repair. The effect depends on where inflammation occurs, how strong it is and how long it lasts.
Can vitamin D directly reduce activity in a chain of inflammation signals?
Yes, experiments have shown specific direct effects on molecules. For example, the vitamin D receptor, which helps cells respond to vitamin D, can interact with a protein involved in switching on genes linked to inflammation.
Does that make vitamin D a treatment for inflammation in general?
No. Blocking a chain of signals in a laboratory experiment is different from improving a disease in people. Vitamin D can affect different immune functions in different ways, depending on the cell and circumstances.
Read the full article below ↓How vitamin D relates to inflammatory signalling and biological messaging
Inflammatory signalling is communication that helps cells detect infection or injury, coordinate defence and organise repair. It involves immune cells, structural tissues, hormones and metabolism. Vitamin D can alter particular pathways, including directly inhibiting some in experimental systems. Describing vitamin D as a regulator should not be taken to exclude direct molecular inhibition, or to establish a universal anti-inflammatory treatment.
From a physiology-first perspective, inflammatory signalling is not inherently harmful. It is a necessary and adaptive process that supports survival and tissue integrity when appropriately regulated. Vitamin D’s relevance lies in how it contributes to proportional signalling and timing within this process, consistent with principles described in whole-system coordination.
What inflammatory signalling involves biologically
Inflammatory signalling begins with detection of disturbance, such as tissue stress, injury, or microbial exposure. Cells respond by releasing signalling molecules that alert neighbouring tissues and recruit immune support. These early signals initiate cascades that influence vascular behaviour, cellular migration, and metabolic allocation. Importantly, inflammatory signalling also contains information that determines when responses should diminish and transition toward recovery.
Rather than functioning as a simple on: off switch, inflammatory signalling operates as a graded communication system. The strength, duration, and spatial reach of signals shape outcomes, making regulation as important as activation.
Vitamin D within inflammatory communication networks
Vitamin D relates to inflammatory signalling through receptor-mediated activity in immune and non-immune cells. These receptors allow vitamin D to influence how cells interpret inflammatory cues and adjust gene expression accordingly. Through this mechanism, vitamin D participates in environments that support signalling clarity and proportional responses rather than indiscriminate amplification.
Because receptor expression and local context vary between tissues, vitamin D’s influence on inflammatory signalling is selective and conditional. This reinforces its role as a contextual regulator rather than a universal anti-inflammatory agent.
Early detection and innate immune signalling
The initiation of inflammatory signalling depends on early detection systems that recognise disturbance or potential threat. These systems operate prominently within barrier tissues and innate immune cells. Vitamin D participates in signalling environments associated with early recognition, helping shape how initial messages are framed and transmitted.
These relationships align with processes described in innate immune signalling and barrier defence coordination, where early signalling influences the trajectory of downstream responses.
Propagation and amplification of inflammatory messages
Once initiated, inflammatory signals may be amplified through cascades involving cytokines and chemokines. These molecules coordinate recruitment of immune cells, alter vascular permeability, and influence metabolic prioritisation. Vitamin D participates in signalling contexts that help modulate how far and how intensely these cascades propagate.
This modulation relates closely to cytokine signalling balance, where proportional communication supports effective defence without unnecessary tissue disruption.
Systemic coordination of inflammatory responses
Inflammatory signalling often extends beyond local tissues to involve systemic coordination. Endocrine signals, neural input, and metabolic adjustments help align immune activity with whole-body needs. Vitamin D contributes to these systemic environments by participating in cross-tissue communication that links local inflammatory events with broader physiological status.
This role reflects broader concepts in systemic physiological regulation, highlighting how inflammatory signalling integrates into whole-body coordination rather than remaining isolated at sites of challenge.
Regulation and containment of inflammatory activity
Effective inflammatory signalling requires containment mechanisms that prevent escalation beyond what is necessary. Regulatory immune cells, feedback loops, and inhibitory signals help limit duration and intensity. Vitamin D participates in signalling environments associated with these regulatory functions, contributing to balance between activation and restraint.
These processes align with principles described in immune modulation networks, where controlled signalling supports resolution and tissue protection rather than prolonged activation.
Transition toward resolution and recovery
Resolution is an active process involving changes in cell activity and chemical messages, removal of inflammatory material and tissue repair. Inhibiting one pathway is different from completing the resolution of an entire inflammatory response. Vitamin D-related mechanisms provide a basis for research, but do not by themselves show that supplementation restores resolution in a particular disease.
This transition connects with concepts in homeostatic regulation, where recovery reflects organised signalling rather than abrupt cessation.
Inflammatory signalling and oxidative stress environments
Inflammation is closely linked to oxidative signalling, as reactive molecules are generated during immune activity. These molecules can support defence but also create stress within surrounding tissues. Vitamin D participates in signalling contexts that influence how oxidative activity is balanced with protective responses.
These relationships overlap with oxidative signalling biology, reinforcing the idea that inflammatory signalling must be coordinated with cellular stress management.
Metabolic alignment during inflammation
Inflammatory signalling places significant metabolic demands on the body. Energy allocation shifts to support immune activity, tissue defence, and repair. Vitamin D participates in signalling environments that help align inflammatory responses with available metabolic resources, supporting proportional activation rather than excessive demand.
This alignment helps explain why inflammatory signalling is closely tied to overall physiological state rather than operating independently of metabolism.
Tissue-specific inflammatory signalling environments
Inflammatory signalling differs across tissues such as skin, lungs, gut, muscle, and connective tissue. Local architecture, exposure patterns, and resident immune populations shape how signals are generated and interpreted. Vitamin D participates in these tissue-specific environments, contributing to locally appropriate signalling rather than uniform responses.
This variability highlights the importance of context in understanding inflammatory biology and avoids oversimplification of vitamin D’s role.
Interaction with stress physiology
Inflammatory signalling intersects with stress-response systems that influence hormonal output, autonomic activity, and behavioural adaptation. Vitamin D participates in signalling environments that overlap with stress regulation, helping coordinate immune responses with broader adaptive processes.
These interactions align with patterns described in stress physiology integration, where immune and stress signalling influence one another.
Life stage influences on inflammatory messaging
Inflammatory signalling changes across the lifespan. Early life emphasises immune development and tolerance, adulthood prioritises balance and resilience, and later life may involve altered signalling dynamics. Vitamin D’s role persists across these stages, contributing to regulatory flexibility rather than fixed inflammatory set points.
These changes reflect broader principles of physiological adaptation rather than linear decline.
Environmental and behavioural context
Sun exposure, sleep patterns, physical activity, and environmental stressors all influence inflammatory signalling. Vitamin D biology is shaped by many of the same factors, creating overlapping influences between lifestyle context and inflammatory tone. This overlap helps explain why inflammatory responses vary widely even among individuals with similar exposures.
Such variation underscores the importance of context-dependent regulation.
Individual variability in inflammatory responses
Genetics, receptor sensitivity, nutritional status, and body composition all influence how inflammatory signals are generated and resolved. Vitamin D’s contribution therefore differs between individuals, reflecting variation in signalling environments rather than uniform effects.
This variability reinforces a systems view in which inflammatory signalling reflects integrated physiology rather than isolated nutrient status.
Inflammatory signalling as an adaptive communication system
Inflammatory signalling coordinates defence, repair and recovery. Vitamin D can support some immune functions and inhibit selected inflammatory pathways, depending on the cell and circumstances. An experimental pathway effect is different from a demonstrated treatment benefit in people.
Its role is embedded within networks that prioritise balance and adaptability.
Integration rather than intervention
From a physiology-first perspective, vitamin D does not intervene in inflammatory signalling as a treatment. Instead, it contributes to the regulatory environments that allow signalling to unfold appropriately. By supporting coherence across immune, metabolic, and endocrine domains, vitamin D helps align inflammatory responses with overall physiological context.
This integrated role explains why vitamin D cannot be reduced to a single inflammatory outcome.
Inflammatory signalling within long-term physiological regulation
Inflammatory signalling is one component of long-term physiological maintenance. The ability to mount, regulate, and resolve inflammation supports tissue integrity and resilience across life. Vitamin D’s participation in this system reflects broader patterns of whole-body regulation in which communication, timing, and proportion determine outcomes.
Understanding vitamin D within this framework avoids reductionist interpretations and supports a systems-level view of inflammatory biology.
A direct molecular effect does not establish a treatment
Chen and colleagues showed an interaction between the vitamin D receptor and IKKβ, a protein involved in activating the NF-κB inflammatory pathway. These mechanistic experiments support direct pathway inhibition under the tested conditions. They do not demonstrate treatment of every inflammatory disease or suppression of all immune functions.
Sources for these clarifications
Aranow C. Vitamin D and the immune system. Journal of Investigative Medicine. 2011;59(6):881 to 886. DOI: 10.2310/JIM.0b013e31821b8755. Review of innate and adaptive immune mechanisms.
Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. Journal of Biological Chemistry. 2013;288(27):19450 to 19458. DOI: 10.1074/jbc.M113.467670. Mechanistic experiments, not a trial of treatment for chronic inflammatory disease.
Bikle DD. Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chemistry & Biology. 2014;21(3):319 to 329. DOI: 10.1016/j.chembiol.2013.12.016. Review of metabolism and receptor signalling.
Related reading
Adipokines, Vitamin D, and Selected Inflammatory Biomarkers among Parkinson’s Disease Patients with and without Dyskinesia: A Preliminary Examination
Patients with dyskinesia exhibited notably higher IL-6 levels compared to controls, and TNF-α was significantly elevated in both PD patient groups relative to the control group.
Original paper ↗Read more →Association between serum vitamin D levels and polycystic ovary syndrome: a cross-sectional study
This study aimed to evaluate the association between serum VD levels and the risk of PCOS, and to explore potential modifying effects across different populations.
Original paper ↗Read more →Changes in pro-inflammatory markers and leucine concentrations in response to Nordic Walking training combined with vitamin D supplementation in elderly women
Rise of myokine irisin induced by exercise correlated inversely with HMGB1 and the correlation was more pronounced at the baseline as well as after training among MVD participants.
Original paper ↗Read more →Characteristics of the Inflammatory Bowel Disease in Children: A Croatian Single-Centre Retrospective Study
We aimed to profile pediatric IBD patients in Croatia through a retrospective analysis of children up to 18 years old diagnosed with IBD at the University Hospital of Split from 1 January 2012, to 31 December 2021, utilizing data collected during hospitalization for diagnosis.
Original paper ↗Read more →Dietary inflammatory index is associated with Vitamin D in CKD patients
We aim to assess the association between dietary inflammatory index (DII) with Vitamin D in adults with CKD.
Original paper ↗Read more →Effect of calcitriol supplementation on infectious biomarkers in patients with positive systemic inflammatory response: A Randomized Controlled Trial
The serum levels of procalcitonin and presepsin were evaluated on days 0, 3, and 5 after administration.
Original paper ↗Read more →From nutritional intervention to immune modulation: a multi-database bibliometric and topic modeling study of vitamin D in inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic condition characterized by recurrent inflammatory episodes in the gastrointestinal tract.
Original paper ↗Read more →Genotype Prevalence of Lactose Deficiency, Vitamin D Deficiency, and the Vitamin D Receptor in a Chilean Inflammatory Bowel Disease Cohort: Insights from an Observational Study
Lactose intolerance (LI) and vitamin D deficiency (VDD) have been linked to inflammatory bowel disease (IBD).
Original paper ↗Read more →Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients
In addition, circulating 25(OH)D3 progression was evaluated according to vitamin D supplementation.
Original paper ↗Read more →Investigation of 20S-hydroxyvitamin D3 analogs and their 1α-OH derivatives as potent vitamin D receptor agonists with anti-inflammatory activities
20S-hydroxyvitamin D3 [20S(OH)D3] is anti-inflammatory and not hypercalcemic, suggesting its potential as a lead compound.
Original paper ↗Read more →Prevalence and Clinical Correlates of Fibromyalgia Screening Positivity in Patients with Inflammatory Bowel Disease
Demographic data, comorbidities, medication exposure, IBD characteristics, disease activity, and laboratory parameters were extracted from the medical records and compared between patients with and without FM.
Original paper ↗Read more →Proposal of a bioinformatics approach to predict molecular mechanisms involved in inflammatory response: case of ATRA and 1,25(OH)2D in adipocytes
In the present study, we aimed to implement a new bioinformatics approach to unveil commonly regulated signalling pathways through a combination of gene and miRNA expression sets impacted by ATRA and 1,25(OH)2D in adipocytes.
Original paper ↗Read more →Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease: Do We Already Know Everything?
Material and methods: The aim of the study is to assess the frequency and risk factors of OST among 232 patients with IBD compared to a group of 199 patients without IBD.
Original paper ↗Read more →TGF Beta Induces Vitamin D Receptor and Modulates Mitochondrial Activity of Human Pancreatic Cancer Cells
In this study, we investigated the interplay between TGFβ and vitamin D in two models of human pancreatic cancer, and we analyzed the metabolic effects of a prolonged TGFβ treatment mimicking the inflammatory environment of pancreatic cancer in vivo.
Original paper ↗Read more →The Effects of 12 Weeks Colostrum Milk Supplementation on the Expression Levels of Pro-Inflammatory Mediators and Metabolic Changes among Older Adults: Findings from the Biomarkers and Untargeted Metabolomic Analysis
This study aimed to investigate the effects of bovine colostrum milk supplementation on metabolic changes and the expression of various biomarkers on inflammation, antioxidant and oxidative damage, nutrient metabolism, and genomic stability among older adults.
Original paper ↗Read more →The Preoperative Supplementation With Vitamin D Attenuated Pain Intensity and Reduced the Level of Pro-inflammatory Markers in Patients After Posterior Lumbar Interbody Fusion
The aim of this experimental study was to assess whether 5 weeks of preoperative supplementation with vitamin D affects the intensity of pain and the level of inflammatory markers in patients undergoing posterior lumbar interbody fusion (PLIF) followed by rehabilitation.
Original paper ↗Read more →The Relationship Between Novel Inflammatory Markers and Serum 25‐Hydroxyvitamin D Among US Adults
Recent studies have investigated the correlation between serum 25‐hydroxyvitamin D (25(OH)D) and common inflammatory markers.
Original paper ↗Read more →Tissue Advanced Glycation End Product Accumulation and Its Association with Clinical and Laboratory Features, Inflammatory Indices, and Comorbidities in Rheumatoid Arthritis and Ankylosing Spondylitis: A Case-Control Study
AGE-SAF is elevated in inflammatory rheumatic diseases compared with healthy controls, and this elevation persists after adjustment for age, sex, and BMI.
Original paper ↗Read more →Transglutaminase 2 Up-Regulation Is Associated with Inflammatory Response in PBMC from Healthy Subjects with Hypovitaminosis D
Given that the maintenance of immune system functions requires an optimal vitamin D status, we aimed to assess the involvement of TG2/NF-κB signaling in cytokine production in PBMC isolated from adult subjects with different vitamin D status.
Original paper ↗Read more →Vitamin D Axis in Inflammatory Bowel Diseases: Role, Current Uses and Future Perspectives
Increasing evidence supports the concept that the vitamin D axis possesses immunoregulatory functions, with vitamin D receptor (VDR) status representing the major determinant of vitamin D’s pleiotropic effects.
Original paper ↗Read more →Vitamin D modulates inflammatory response of DENV-2-infected macrophages by inhibiting the expression of inflammatory-liked miRNAs
Further, we evaluated the effects of inhibition of these miRNAs in the innate immune response.
Original paper ↗Read more →Original sources
Vitamin D and the immune system
Published in Journal of Investigative Medicine (2011).
Publication details
Aranow C. Vitamin D and the immune system. Journal of Investigative Medicine. 2011;59(6):881 to 886. DOI: 10.2310/JIM.0b013e31821b8755. Review of innate and adaptive immune mechanisms.
Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein
Published in Journal of Biological Chemistry (2013).
Publication details
Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein. Journal of Biological Chemistry. 2013;288(27):19450 to 19458. DOI: 10.1074/jbc.M113.467670. Mechanistic experiments, not a trial of treatment for chronic inflammatory disease.
Vitamin D Metabolism, Mechanism of Action, and Clinical Applications
Published in Chemistry & Biology (2014).
Publication details
Bikle DD. Vitamin D Metabolism, Mechanism of Action, and Clinical Applications. Chemistry & Biology. 2014;21(3):319 to 329. DOI: 10.1016/j.chembiol.2013.12.016. Review of metabolism and receptor signalling.